| Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era M Kostakioti, M Hadjifrangiskou, SJ Hultgren Cold Spring Harbor perspectives in medicine 3 (4), a010306, 2013 | 1196 | 2013 |
| Escherichia coli biofilms have an organized and complex extracellular matrix structure C Hung, Y Zhou, JS Pinkner, KW Dodson, JR Crowley, J Heuser, ... MBio 4 (5), 10.1128/mbio. 00645-13, 2013 | 240 | 2013 |
| Options and limitations in clinical investigation of bacterial biofilms M Magana, C Sereti, A Ioannidis, CA Mitchell, AR Ball, E Magiorkinis, ... Clinical Microbiology Reviews 31 (3), 10.1128/cmr. 00084-16, 2018 | 222 | 2018 |
| Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection K Nagamatsu, TJ Hannan, RL Guest, M Kostakioti, M Hadjifrangiskou, ... Proceedings of the National Academy of Sciences 112 (8), E871-E880, 2015 | 174 | 2015 |
| QseC‐mediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli M Kostakioti, M Hadjifrangiskou, JS Pinkner, SJ Hultgren Molecular microbiology 73 (6), 1020-1031, 2009 | 172 | 2009 |
| A central metabolic circuit controlled by QseC in pathogenic Escherichia coli M Hadjifrangiskou, M Kostakioti, SL Chen, JP Henderson, SE Greene, ... Molecular microbiology 80 (6), 1516-1529, 2011 | 127 | 2011 |
| Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors M Hadjifrangiskou, AP Gu, JS Pinkner, M Kostakioti, EW Zhang, ... Journal of bacteriology 194 (22), 6195-6205, 2012 | 118 | 2012 |
| Pathogenic H elicobacter pylori strains translocate DNA and activate TLR9 via the cancer-associated cag type IV secretion system MG Varga, CL Shaffer, JC Sierra, G Suarez, MB Piazuelo, ME Whitaker, ... Oncogene 35 (48), 6262-6269, 2016 | 116 | 2016 |
| Metabolic requirements of Escherichia coli in intracellular bacterial communities during urinary tract infection pathogenesis MS Conover, M Hadjifrangiskou, JJ Palermo, ME Hibbing, KW Dodson, ... MBio 7 (2), 10.1128/mbio. 00104-16, 2016 | 103 | 2016 |
| Strong cross-system interactions drive the activation of the QseB response regulator in the absence of its cognate sensor KR Guckes, M Kostakioti, EJ Breland, AP Gu, CL Shaffer, CR Martinez III, ... Proceedings of the National Academy of Sciences 110 (41), 16592-16597, 2013 | 101 | 2013 |
| Adhesive Fiber Stratification in Uropathogenic Escherichia coli Biofilms Unveils Oxygen-Mediated Control of Type 1 Pili KA Floyd, JL Moore, AR Eberly, JAD Good, CL Shaffer, H Zaver, ... PLoS pathogens 11 (3), e1004697, 2015 | 99 | 2015 |
| Molecular blueprint of uropathogenic Escherichia coli virulence provides clues toward the development of anti-virulence therapeutics M Kostakioti, SJ Hultgren, M Hadjifrangiskou Virulence 3 (7), 592-593, 2012 | 84 | 2012 |
| Biofilm Formation by Uropathogenic Escherichia coli Is Favored under Oxygen Conditions That Mimic the Bladder Environment AR Eberly, KA Floyd, CJ Beebout, SJ Colling, MJ Fitzgerald, CW Stratton, ... International journal of molecular sciences 18 (10), 2077, 2017 | 80 | 2017 |
| Pilicide ec240 disrupts virulence circuits in uropathogenic Escherichia coli SE Greene, JS Pinkner, E Chorell, KW Dodson, CL Shaffer, MS Conover, ... MBio 5 (6), 10.1128/mbio. 02038-14, 2014 | 79 | 2014 |
| Respiratory heterogeneity shapes biofilm formation and host colonization in uropathogenic Escherichia coli CJ Beebout, AR Eberly, SH Werby, SA Reasoner, JR Brannon, S De, ... MBio 10 (2), 10.1128/mbio. 02400-18, 2019 | 71 | 2019 |
| Invasion of vaginal epithelial cells by uropathogenic Escherichia coli JR Brannon, TL Dunigan, CJ Beebout, T Ross, MA Wiebe, WS Reynolds, ... Nature communications 11 (1), 2803, 2020 | 69 | 2020 |
| Adhesion of bacteria to surfaces and biofilm formation on medical devices KA Floyd, AR Eberly, M Hadjifrangiskou Biofilms and implantable medical devices, 47-95, 2017 | 69 | 2017 |
| The arsenal of pathogens and antivirulence therapeutic strategies for disarming them JR Brannon, M Hadjifrangiskou Drug design, development and therapy, 1795-1806, 2016 | 60 | 2016 |
| An Overview of Two-Component Signal Transduction Systems Implicated in Extra-Intestinal Pathogenic E. coli Infections EJ Breland, AR Eberly, M Hadjifrangiskou Frontiers in cellular and infection microbiology 7, 162, 2017 | 57 | 2017 |
| The Alternative Sigma Factor σH Is Required for Toxin Gene Expression by Bacillus anthracis M Hadjifrangiskou, Y Chen, TM Koehler Journal of bacteriology 189 (5), 1874-1883, 2007 | 56 | 2007 |
